CD8A and neoplasm: We demonstrated that Gal1‐induced TAMs activated the CCL20 release via stimulating the PI3K/AKT/NF‐κB pathway, therefore triggering the recruitment of CCR6+Foxp3+ Tregs that impaired the anti‐tumor response of CD8+ T cells.